RECENT NEWS

The Testing Times report reflects expert opinion that supporting more widespread use of rapid diagnostic technology should be a central aim of efforts to tackle the next hidden pandemic.

Gilead Sciences has announced the completion of its deal to acquire MiroBio, for approximately $405 million in cash.

Torrey Pines Scientific has launched its new EchoTherm Model HS70 corrosion-resistant fully programmable digital stirring hot plates.

Understanding where and how protein spikes invade healthy cells could advance the fight against COVID-19 and other viral illnesses.

AetherAI, Asia’s leading medical image AI solution provider, has designed an AI-assisted lymph node assessment workflow, validated with clinical experiments, and revealed the improvement of micrometastasis identification sensitivity from 81% to 95%.

The company’s newest osmometer delivers the automation and data management capabilities modern clinical laboratories require to free up staff time, improve result turnaround times, reduce errors, and ensure effortless compliance.

The diagnostic services provider projects DermAI may decrease turnaround time for melanoma cases by 30-40%.

Grail has announced final results from the interventional Pathfinder study, which evaluated multi-cancer early detection (MCED) screening using a blood test and the clinical care pathways following a “cancer signal detected” MCED test result in 6,662 individuals aged 50 years or older, an age group at elevated risk for cancer.

Beckman Coulter Life Sciences has acquired ValitaCell, a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry.

Image data from multiple hospitals improves the tool’s versatility and accuracy.

Deciphex, a leading provider of digital pathology software and services, has launched its Diagnexia service in the United States.

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, hav announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.

PhoreMost will deploy its Siteseeker platform to identify novel targets for Roche’s discovery programmes.

A laboratory service in a local hospital in West Bengal, India, is continuing to benefit from UK support offered by Mast Group and others post-COVID.

Aleiya Lonsdale, Head of Event, at Lab Innovations, explains how pharmaceutical companies in the UK can do their part to help tackle carbon emissions and reach the NHS’ net-zero goal when developing drugs.

My Pathomation's newest release focuses on promoting grassroot initiatives in digital pathology. Anybody can sign up for a free account and get involved with digital pathology this way. Users now upload and tag theirs slides, share them as public collections, or produce online course content within their own organisation.

The digital pathology platform will improve collaboration across the hospital's multi-site network and lay the foundation for unlocking new diagnostic insights with AI.

Takara Bio Europe (TBE) has announced a new partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.

The latest version of Galen transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user interface, and workflow integration capabilities.

The Tissue-Tek Genie provides optimal slides with the same turnaround time, using one protocol and achieving optimal staining quality across the entire 130+ Sakura antibody portfolio.